January 1, 2008Current OncologyOpen Access

Cardiac Management during Adjuvant Trastuzumab Therapy: Recommendations of the Canadian Trastuzumab Working Group

View Full Paper

Ask AI

Bookmark

Population

Women with her2-positive breast cancer receiving adjuvant trastuzumab therapy

Design

Guideline

Authors

JMJohn R. MackeyCardio-Oncology MCM. ClemonsOttawa Hospital MCMarc André CôtéCentre hospitalier de l'Université Laval

Discussion

Member takes

Implication

Guides cardiac risk assessment, monitoring, and management during adjuvant trastuzumab; reinforces expert consensus for cardio-oncology practice.

Structured PICO

Population

Women with her2-positive breast cancer receiving adjuvant trastuzumab therapy

Intervention

Cardiac assessment and management protocols

This document provides expert recommendations from the Canadian Trastuzumab Working Group for the assessment and management of cardiac complications in patients receiving adjuvant trastuzumab therapy.

Cite This Study

Mackey et al. (2008) studied this question.

synapsesocial.com/papers/6a735cfc64cdd4095c2c27d2 https://doi.org/10.3747/co.2008.199

View Full Paper

Ask AI

Bookmark

Implication

Guides cardiac risk assessment, monitoring, and management during adjuvant trastuzumab; reinforces expert consensus for cardio-oncology practice.

Cardiac Management during Adjuvant Trastuzumab Therapy: Recommendations of the Canadian Trastuzumab Working Group

Discussion

Member takes

Implication

Structured PICO

Cite This Study

Cardiac Management during Adjuvant Trastuzumab Therapy: Recommendations of the Canadian Trastuzumab Working Group

Discussion

Member takes

Implication

Structured PICO

Cite This Study

Also Consider

Also Consider